Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 979-990

  Amedei, Amedeo ^a,b   Della Bella, C ^a   Niccolai, E ^a   Stanflin, N ^b   Benagiano, M ^a   Duranti, R ^a   Del Prete, G ^a,b   Murphy, T F ^c   D'Elios, M M ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c BUFFALO STATE COLLEGE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Moraxella catarrhalis; Specific T cell; Th1

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; MACROPHAGE ELASTASE;

ADULT; AGED; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; IN VIVO STUDY; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MALE; MOLECULAR CLONING; MONOCYTE; MORAXELLA CATARRHALIS; MORAXELLACEAE INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL;

EID: 76349111568     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200413     Document Type: Article

References (34)

1. Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 2007; 4:e112.
2. Filley GF. Emphysema and chronic bronchitis: clinical manifestations and their physiologic significance. Med. Clin. North Am 1967; 51:283-92.
3. Finkelstein R, Ma HD, Ghezzo H, Whittaker K, Fraser RS, Cosio MG. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med 1995; 152:267-76.
4. Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:1259-65.
5. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109:288-95.
6. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research Proc Am Thorac Soc 2007; 4:512-21.
7. Murphy TF, Brauer AL, Aebi C, Sethi S. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun 2005; 73:8161-6.
8. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001; 46:798-825.
9. Del Prete GF, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type I (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med 1991; 174:809-13.
10. Romagnani S, Del Prete G, Maggi E, Bellesi G, Biti G, Rossi Ferrini PL, Ricci M. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease J Clin Invest 1983; 71:1375-82.
11. Del Prete G, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23:1445-9.
12. Hodge G, Nairn J, Holmes M, Reynolds PN, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007; 150:22-29.
13. Costa C, Rufino R, Traves SL, Lapa E, Silva JR, Barnes PJ, Donnelly LE. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 2008; 133:26-33.
14. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129-34.
15. Di Stefano A, Capelli A, Lusuardi M, et al. Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy 2001; 31:893-902
16. Bacon CM, Petricoin EF 3rd, Ortaldo JR, Rees RC, Larner AC, Johnston JA, O'Shea JJ. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 1995; 92:7307-11.
17. Di Stefano A, Caramori G, Capelli A, et al. STAT-4 activation in smokers and patients with COPD. Eur Respir J 2004; 24:78-85.
18. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002; 347:465-71.
19. Slevogt H, Seybold J, Tiwari KN, et al. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol 2007; 9:694-707.
20. N'Guessan PD, Vigelahn M, Bachmann S, et al. The UspA1 protein of Moraxella catarrhalis induces CEACAM-1-dependent apoptosis in alveolar epithelial cells. J Infect Dis 2007; 195:1651-60.
21. Tagaya E, Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 2007; 56:331-340.
22. Ashino S, Nishimura T. Critical role of IFN-alpha/beta and IFN-gamma in the regulation of airway inflammation Nippon Rinsho 2006; 64:1260-8.
23. Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med 1999; 190:1309-1318.
24. Hallsworth MP, Soh CPC, Twort CHC, Lee TH, Hirst SJ. Cultured human airway smooth muscle cells stimulated by interleukin-1β enhance eosinophil survival. Am J Respir Cell Mol Biol 1998; 19:910-19.
25. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-53.
26. Mercer BA, Kolesnikova N, Sonett J, D'Armiento J. Extracellular regulated kinase/mitogen activated protein kinase is upregulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 2004; 279:17690-6.
27. Ofulue, AF, Ko M. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol 1999; 277:97-105.
28. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-4.
29. Plataki M, Tzortzaki E, Rytila P, Demosthenes M, Koutsopoulos A, Siafakas NM. Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis 2006; 1:161-171.
30. Park JW, Ryter SW, Choi AM. Functional significance of apoptosis in chronic obstructive pulmonary disease. COPD 2007; 4:347-53.
31. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17: 946-53.
32. Ma B, Blackburn MR, Lee CG, et al, Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 2006; 116:1274-83.
33. Wei YQ, Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 2000; 6:1160-6.
34. Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc 2006; 3:687-90.